Inventor · disambiguated record
Michael Torgov
Also filed as: TORGOV MICHAEL · TORGOV MICHAEL Y · TORGOV MICHAEL YURI
51 granted patents·14 pending applications·474 citations·filing 2005–2025
99Inventor score
Top patents by PatentIndex Score
65 records- 0198US11033634B2Light chain variable regionsABBVIE STEMCENTRX LLC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0297US11559582B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2020·Granted Jan 24, 2023·3 cites·32 claims
- 0397US9089615B2Anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·21 cites·30 claims
- 0497US8986972B2Nucleic acid encoding DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Mar 24, 2015·22 cites·30 claims
- 0597US7837980B2Partially loaded antibodies and methods of their conjugationSEATTLE GENETICS INC·Filed 2005·Granted Nov 23, 2010·98 cites·26 claims
- 0696US9937268B2Anti-DLL3 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 10, 2018·9 cites·30 claims
- 0796US9931421B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0896US9931420B2Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0996US9878053B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 30, 2018·9 cites·30 claims
- 1096US9867887B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 16, 2018·9 cites·30 claims
- 1196US9861708B2Kits containing DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 9, 2018·9 cites·30 claims
- 1296US9855343B2Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 2, 2018·9 cites·30 claims
- 1396US9775916B1Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2017·Granted Oct 3, 2017·9 cites·30 claims
- 1496US9770518B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 26, 2017·9 cites·30 claims
- 1596US9764042B1Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 19, 2017·9 cites·30 claims
- 1696US9358304B1Methods of making DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Jun 7, 2016·10 cites·30 claims
- 1796US9352051B1Kits containing DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 31, 2016·10 cites·30 claims
- 1896US9353182B2Anti-DLL3 antibodiesSTEMCENTRX INC·Filed 2015·Granted May 31, 2016·10 cites·21 claims
- 1996US9334318B1Multivalent DLL3 antibodiesSTEMCENTRX INC·Filed 2016·Granted May 10, 2016·11 cites·28 claims
- 2096US9155803B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Oct 13, 2015·10 cites·30 claims
- 2196US9133271B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Sep 15, 2015·10 cites·30 claims
- 2296US9089617B2Anti-DLL3 antibody drug conjugatesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·13 cites·30 claims
- 2395US10137204B2Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2016·Granted Nov 27, 2018·8 cites·33 claims
- 2495US9486537B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 8, 2016·9 cites·22 claims
- 2595US9480757B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·9 cites·29 claims
- 2695US9107961B2Anti-DLL3 antibody drug conjugates for treating cancerSTEM CENTRX INC·Filed 2014·Granted Aug 18, 2015·11 cites·30 claims
- 2795US9089616B2Anti-DLL3 antibody drug conjugates and methods of useSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2894US9090683B2Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2993US10894090B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2018·Granted Jan 19, 2021·4 cites·38 claims
- 3093US9314538B2Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2015·Granted Apr 19, 2016·9 cites·33 claims
- 3192US9078931B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2013·Granted Jul 14, 2015·11 cites·8 claims
- 3291US9962454B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2016·Granted May 8, 2018·6 cites·5 claims
- 3390US11884688B2Borylated amino acid compositions comprising BTS and BTS(OMe) for use in boron neutron capture therapy and methods thereofTAE Life Sciences·Filed 2022·Granted Jan 30, 2024·2 cites·3 claims
- 3490US10478509B2Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2018·Granted Nov 19, 2019·6 cites·30 claims
- 3590US9345784B1Methods of delivering DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 24, 2016·3 cites·30 claims
- 3690US8637642B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsSATPAYEV DAULET·Filed 2011·Granted Jan 28, 2014·12 cites·15 claims
- 3789US12319707B2Dosage unit form(s) comprising BTS and BTS(OMe) for use in boron neutron capture therapy and methods thereofTAE Life Sciences·Filed 2023·Granted Jun 3, 2025·1 cites·11 claims
- 3889US11254744B2Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2016·Granted Feb 22, 2022·5 cites·32 claims
- 3989USRE48389EAntibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2017·Granted Jan 12, 2021·2 cites·110 claims
- 4089US9676850B2Anti SEZ6 antibodies and methods of useSTEM CENTRX INC·Filed 2013·Granted Jun 13, 2017·10 cites·12 claims
- 4189US9173959B1Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2015·Granted Nov 3, 2015·3 cites·30 claims
- 4288US9481727B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·2 cites·26 claims
- 4386US2023346968A1Antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2022·Application pending·0 cites
- 4484US11266745B2Extension sequences for diabodiesIMAGINAB INC·Filed 2018·Granted Mar 8, 2022·3 cites·25 claims
- 4583US9308278B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsAGENSYS INC·Filed 2013·Granted Apr 12, 2016·4 cites·14 claims
- 4682US11566031B2Borylated amino acid compositions for use in boron neutron capture therapy and methods thereofTAE Life Sciences·Filed 2020·Granted Jan 31, 2023·1 cites·5 claims
- 4782US8609092B2Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsTORGOV MICHAEL·Filed 2011·Granted Dec 17, 2013·6 cites·5 claims
- 4880US11219689B2Boron enriched linker (“BEL”) compositions for boron neutron capture therapy and methods thereofTAE Life Sciences·Filed 2019·Granted Jan 11, 2022·1 cites·17 claims
- 4980US8846873B2Antibodies directed to GPNMB and uses thereofXIAO FENG·Filed 2012·Granted Sep 30, 2014·9 cites·27 claims
- 5079US2025034176A1Borylated Amino Acid Compositions For Use In Boron Neutron Capture Therapy and Methods ThereofTAE LIFE SCIENCES LLC·Filed 2024·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Torgov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →